It was indicated in the correlation analysis of clinical prognosis that HCM patients with genotype GG of ACE2 gene polymorphism rs102312 exhibited significantly increased incidence rates of major adverse cardiovascular and cerebrovascular event (MACCE), sudden death, stroke and cardiac death compared with those carrying genotype TT (p<0.05) (Table 9). The gene discussed is ACE2; the disease is stroke disorder.